Silversmith’s Jeff Crisan and Jim Quagliaroli were named to GrowthCap’s Top 25 inaugural Healthcare Investors list. GrowthCap evaluated deal experience and track record, strategic and operational capabilities provided to portfolio companies, unique and differentiated attributes, as well as contributions to charitable work and overall industry advancement in determining the 25 healthcare investors named to the list.

As noted by GrowthCap, “Healthcare plays a crucial role in the quality of lives, underpins all other business and economic activity, and ultimately determines the state of our world, and these accomplished individuals have demonstrated a deep commitment to healthcare and as a result have succeeded both from a business standpoint as well as in having significant societal impact.”

Jeff co-founded Silversmith Capital Partners in 2015. In his role as a Managing Partner, Jeff focuses on investments in Healthcare IT & Services. Jeff has led many of the firm’s healthcare investments including Iodine Health, LifeStance Health, MediQuant, Nordic, Panalgo, Partners Surgical, Sound Physicians, Upperline Health and Within3. Some of Jeff’s notable investments prior to co-founding Silversmith included ABILITY Network, Liberty Dialysis, Liazon and MedHOK.  

Jim co-founded Silversmith Capital Partners in 2015. In his role as Managing Partner, Jim focuses on investments across the firm’s two core verticals: SaaS & Information Services and Healthcare IT & Services. At Silversmith, he serves on the board of Centauri Health Solutions, Market Access Transformation, and Net Health. Prior to co-founding Silversmith, Jim served on the board of Passport Health (acquired by Experian) and MedHOK (acquired by Hearst). Over his career, he has served on the board of 20+ companies.

Read more about Jeff, Jim and their fellow honorees here.

The Firm Recognitions presented herein are from third-parties that are not affiliated with Silversmith. These third-parties independently assess nominees based on multiple criteria. The awards and designations presented on this website are the opinion of the respective parties conferring the award or designation and not of Silversmith. Recognitions by third-parties are not indicative of future performance. Silversmith pays a licensing or related fee to participate and/or distribute the results. The receipt of compensation influences, and is likely to present a potential material conflict of interest, relating to any granted award or designation. There can be no assurance that other providers or surveys would reach the same conclusions as the foregoing.  

Silversmith submitted nominations to be considered for the GrowthCap Top 25 Healthcare Investors of 2021 award and has paid a fee to promote this award. For additional details on the award selection criteria and methodology, please visit https://growthcapadvisory.com/the-top-25-healthcare-investors-of-2021/